arrow
O

Olivier Mir

Université Paris Saclay
H指数:65
被引数:1.5万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Adjuvant chemotherapy and hormonotherapy versus adjuvant hormonotherapy alone for women aged 70 years and older with high-risk breast cancer based on the genomic grade index (ASTER 70s): a randomised phase 3 trial

基于基因组分级指数的高龄(≥70岁)高风险乳腺癌患者辅助化疗联合内分泌治疗与单纯辅助内分泌治疗的比较(ASTER 70s):一项随机III期临床试验

2025-07-310
PRE
Role of PIK3CA as a predictive biomarker in metastatic, imatinib-resistant GIST: A ct-DNA substudy of the VOYAGER trial

PIK3CA作为预测性生物标志物在转移性、伊马替尼耐药GIST中的作用:VOYAGER试验的细胞游离DNA亚组研究

2024-09-010
PRE
Digital remote monitoring plus usual care versus usual care in patients treated with oral anticancer agents: the randomized phase 3 CAPRI trial
2022-04-2553
OA
Patterns of care and outcomes of 417 patients with METAstatic SYNovial sarcoma (METASYN): real-life data from the French Sarcoma Group (FSG)
2022-04-0110
OAAI
Outcomes of Patients With Active Cancer and COVID-19 in the Intensive-Care Unit: A Multicenter Ambispective Study
2022-03-109
OAAI
Systemic treatment in advanced phyllodes tumor of the breast: a multi-institutional European retrospective case-series analyses

晚期乳腺叶状肿瘤的系统治疗: 一项多机构欧洲回顾性病例系列分析

2022-02-129
OA
Gastrointestinal stromal tumours: ESMO-EURACAN-GENTURIS Clinical Practice Guidelines for diagnosis, treatment and follow-up

胃肠道间质瘤: esmo-euracan-GENTURIS诊断,治疗和随访的临床实践指南

2022-01-01269
OAAI